Navigation Links
Hypothermia underutilized in cardiac arrest cases treated in US hospitals
Date:1/4/2012

New Rochelle, NY -- Therapeutic hypothermia has been proven to reduce mortality and improve neurologic outcomes after a heart attack, yet it was rarely used in a sample of more than 26,000 patients, according to a study published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is available at www.liebertpub.com/ther

Therapeutic hyperthermia was used in only 0.35% of cases of out-of-hospital cardiac arrest in this study. The authors, Pratik Patel, Sayona John, Rajeev Garg, Richard Temes, Thomas Bleck, and Shyam Prabhakaran, from Rush University Medical Center, Chicago, IL, state that "Continued education, dissemination of evidence-based guidelines to community hospitals, the development of and preferential transport of patients to designated cardiac arrest treatment centers, and enhanced reimbursement may help increase its application in clinical practice." The article is entitled "Therapeutic Hypothermia After Cardiac Arrest is Underutilized in the United States." (http://www.liebertonline.com/doi/pdfplus/10.1089/ther.2011.0015)

"This informative study underscores the need to more efficiently target and treat cardiac arrest patients that would benefit from hypothermic therapy. The fact that therapeutic hypothermia is underutilized at U.S. hospitals emphasizes the need to identify and address barriers to this evidence-based therapy," says W. Dalton Dietrich, PhD, Editor-in-Chief of the Journal and Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine.


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. New findings on therapeutic hypothermia following cardiac arrest in children
2. Stevens biomedical engineering students fight hypothermia on the battlefield
3. Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest
4. Therapeutic Hypothermia journal launching in spring 2011
5. Suspended animation protects against lethal hypothermia, study shows
6. Therapeutic hypothermia is promising strategy to minimize tissue damage
7. Genetic testing for breast or ovarian cancer risk may be greatly underutilized
8. Geoscientists find key to why some patients get infections from cardiac implants
9. Adrenaline use in cardiac arrest
10. Johns Hopkins researchers identify new genetic risk factor for sudden cardiac death
11. Outcomes for cardiac valve procedure patients are affected by insurance status
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hypothermia underutilized in cardiac arrest cases treated in US hospitals
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: